Camostat

Explore Camostat, a serine protease inhibitor. Learn about its mechanism of action, medical uses in pancreatitis and other conditions, dosage, and potentia

Camostat Camostat mechanism of action Camostat for pancreatitis Camostat side effects Camostat dosage Is Camostat approved for COVID-19 Camostat drug interactions Serine protease inhibitor uses Camostat clinical trials
🕐 Updated: Mar 12, 2026 ✓ Medical Reference

Looking to order Camostat?

Browse our catalog for available pharmaceutical products and competitive pricing.

What is Camostat?

Camostat is a synthetic, orally active serine protease inhibitor developed in Japan. It has gained significant attention for its potential therapeutic applications across various medical conditions. As a protease inhibitor, it works by blocking the activity of specific enzymes crucial for numerous biological processes, including inflammation, blood coagulation, and viral entry into cells. Its unique mechanism makes it a subject of extensive research for use in conditions ranging from pancreatic diseases to viral infections.

How Does it Work?

The primary mechanism of action of Camostat involves inhibiting serine proteases. It targets enzymes like trypsin, plasmin, kallikrein, and especially transmembrane protease, serine 2 (TMPRSS2). By inhibiting TMPRSS2, Camostat can prevent the activation of spike proteins of certain viruses, hindering their ability to infect host cells. This action has made it a significant candidate in COVID-19 research. Beyond viral inhibition, its effects on other proteases contribute to its anti-inflammatory and anti-fibrotic properties, beneficial in conditions like pancreatitis treatment. The drug acts as a molecular "brake" on these enzymes, preventing them from carrying out pro-inflammatory or pro-viral functions.

Medical Uses

Historically, Camostat has been approved in Japan for treating chronic pancreatitis and postoperative reflux esophagitis.

  • Chronic Pancreatitis: It helps reduce inflammation and pain by inhibiting pancreatic enzyme activity, alleviating symptoms and potentially slowing disease progression.
  • Postoperative Reflux Esophagitis: Its anti-inflammatory properties manage reflux esophagitis after certain surgeries.

More recently, Camostat has gained international attention for its potential role in treating viral infections.

  • COVID-19: Due to its ability to inhibit TMPRSS2, an enzyme essential for SARS-CoV-2 entry, Camostat has been investigated in clinical trials as a potential treatment. While early research showed promise, larger studies are ongoing.
  • Other Potential Uses: Researchers are exploring Camostat for its anti-fibrotic effects in liver fibrosis and kidney disease, and for certain cancers where protease activity contributes to tumor growth.

Dosage

The Camostat dosage varies significantly by condition and patient response. For chronic pancreatitis, the typical dosage in Japan is often 200 mg orally three times a day. For other conditions, especially those under investigation like COVID-19, dosage regimens are still being established through clinical trials. Camostat is a prescription medication; its use must always be guided by a qualified healthcare professional. Self-medication is strongly discouraged due to potential risks and the need for medical supervision to monitor efficacy and adverse effects. Patients should never adjust their dosage without consulting their doctor.

Side Effects

Like all medications, Camostat can cause side effects, though not everyone experiences them. Common side effects can include:

  • Gastrointestinal disturbances: nausea, vomiting, abdominal pain, diarrhea.
  • Allergic reactions: rash, itching.
  • Liver enzyme elevations, usually resolving upon discontinuation.
  • Blood dyscrasias: decreased white blood cell count (leukopenia) or platelets (thrombocytopenia), though less common.

Serious side effects are rare but can include severe hypersensitivity reactions or significant hematological issues. Patients should report any unusual symptoms to their doctor immediately. Regular monitoring of liver function and blood counts may be recommended.

Drug Interactions

Camostat drug interactions can occur with other medications, potentially altering their effects. While comprehensive data is still being gathered, caution is important.

  • Anticoagulants: Camostat, a protease inhibitor, could theoretically interact with blood-thinning medications (e.g., warfarin), potentially increasing bleeding risk. Close monitoring of coagulation is advised.
  • Other Protease Inhibitors: Co-administration might lead to additive effects or increased toxicity.
  • Drugs metabolized by certain enzymes: There's theoretical potential for interaction with drugs metabolized by cytochrome P450 enzymes, though specific clinical interactions are not well-defined.

Patients must inform their healthcare provider about all medications, supplements, and herbal products to avoid potential interactions and ensure safe treatment.

FAQ

  • Is Camostat approved for COVID-19?
    Currently, Camostat is not widely approved for COVID-19 treatment outside of clinical trial settings. Its use for this indication is still under investigation.
  • What is a serine protease inhibitor?
    A serine protease inhibitor is a drug that blocks the activity of serine proteases, enzymes involved in inflammation, blood clotting, and viral replication.
  • Can Camostat cure pancreatitis?
    Camostat helps manage symptoms and progression of chronic pancreatitis but is not a cure. It's part of a broader management strategy.
  • How long does it take for Camostat to work?
    Onset of action varies. For pancreatitis relief, some patients may see improvements within days to weeks. For other conditions, efficacy is assessed over longer periods.
  • Is Camostat safe for long-term use?
    For its approved indications in Japan, Camostat has been used long-term under medical supervision. Long-term use requires regular monitoring for side effects and efficacy.

Products containing Camostat are available through trusted online pharmacies. You can browse Camostat-based medications at ShipperVIP or Medicenter.

Summary

Camostat is a significant serine protease inhibitor with established uses in Japan for chronic pancreatitis and postoperative reflux esophagitis. Its ability to inhibit key enzymes, particularly TMPRSS2, highlights its potential in treating viral infections, including SARS-CoV-2. While its role in conditions like COVID-19 is still being defined through extensive clinical trials, its unique mechanism offers promising avenues for various medical applications. Patients considering Camostat should always consult with a healthcare professional to understand its appropriate uses, dosage, potential drug interactions, and adverse effects, ensuring safe and effective treatment.